Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · IEX Real-Time Price · USD
17.11
+0.78 (4.78%)
At close: Apr 26, 2024, 4:00 PM
16.86
-0.25 (-1.46%)
After-hours: Apr 26, 2024, 7:47 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $1.46 billion as of April 26, 2024. Its market cap has increased by 16,139.90% in one year.
Market Cap
1.46B
Enterprise Value
1.43B
1-Year Change
16,139.90%
Ranking
Category
Stock Price
$17.11
Market Cap Chart
Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $1.46B, an increase of 783.67%. That is a compound annual growth rate of 12.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 1.46B | 4.77% |
Apr 25, 2024 | 1.40B | 1.75% |
Apr 24, 2024 | 1.37B | 0.69% |
Apr 23, 2024 | 1.36B | -0.13% |
Apr 22, 2024 | 1.36B | 2.91% |
Apr 19, 2024 | 1.32B | 0.65% |
Apr 18, 2024 | 1.32B | -2.71% |
Apr 17, 2024 | 1.35B | -1.00% |
Apr 16, 2024 | 1.37B | -2.91% |
Apr 15, 2024 | 1.41B | -1.96% |
Apr 12, 2024 | 1.44B | 2.19% |
Apr 11, 2024 | 1.41B | 18.51% |
Apr 10, 2024 | 1.19B | -18.35% |
Apr 9, 2024 | 1.45B | 0.83% |
Apr 8, 2024 | 1.44B | -0.53% |
Apr 5, 2024 | 1.45B | -0.18% |
Apr 4, 2024 | 1.45B | -1.05% |
Apr 3, 2024 | 1.47B | 1.01% |
Apr 2, 2024 | 1.45B | 7.19% |
Apr 1, 2024 | 1.35B | -9.32% |
Mar 28, 2024 | 1.49B | -0.29% |
Mar 27, 2024 | 1.50B | 3,423.53% |
Mar 26, 2024 | 42.50M | 3.66% |
Mar 25, 2024 | 41.00M | -7.87% |
Mar 22, 2024 | 44.50M | -1.33% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
National HealthCare | 1.40B |
Akero Therapeutics | 1.40B |
Morphic Holding | 1.39B |
Agiliti | 1.37B |
ANI Pharmaceuticals | 1.37B |
AdaptHealth | 1.33B |
Establishment Labs Holdings | 1.33B |
Day One Biopharmaceuticals | 1.33B |